3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
44
Pancreatic Neoplasms
39
Rectal Neoplasms
20
Colonic Neoplasms
19
Stomach Neoplasms
18
Neoplasm Metastasis
16
Esophageal Neoplasms
13
Cholangiocarcinoma
13
Barrett Esophagus
11
Carcinoma, Hepatocellular
10
Ovarian Neoplasms
9
Breast Neoplasms
9
Adenocarcinoma Of Esophagus
9
Melanoma
8
Anus Neoplasms
8
Neoplasms
7
Sarcoma
6
Lung Neoplasms
6
Liver Neoplasms
6
Glioma
6
Gastroesophageal Reflux
6
Gallbladder Neoplasms
6
Uterine Cervical Neoplasms
5
Lymphoma, Non-Hodgkin
5
Hepatoblastoma
5
Esophageal Squamous Cell Carcinoma
5
Endometrial Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Adenomatous Polyposis Coli
5
Wilms Tumor
4
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
4
pimonidazole
2
TH 302
2
pembrolizumab
1
inositol trispyrophosphate
1
gadobutrol
1
fluoromisonidazole
1
Tirapazamine
1
Surgical Procedures, Operative
1
Radiotherapy
1
Propofol
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Ipilimumab
1
Injections
1
Gemcitabine
1
Ethiodized Oil
1
Cisplatin
1
Blood Specimen Collection
1
Biopsy
1
AQ4N
1
4-methylbenzenesulfonic acid
1
3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypoxia
×
Biopsy
×
Gastrointestinal
×
Clear all
NCT02157246
2017-03-13
RHYTHM-I
University of Oxford
Phase NA
Completed
14 enrolled